Alto Neuroscience Inc [ANRO] stock prices are down -2.43% to $4.41 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ANRO shares have gain 4.26% over the last week, with a monthly amount glided 12.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alto Neuroscience Inc [NYSE: ANRO] stock has seen the most recent analyst activity on October 23, 2024, when Wedbush downgraded its rating to a Neutral and also revised its price target to $4 from $29. Previously, Rodman & Renshaw downgraded its rating to Neutral on October 23, 2024. On September 03, 2024, Wedbush initiated with a Outperform rating and assigned a price target of $29 on the stock. William Blair started tracking the stock assigning a Outperform rating. TD Cowen initiated its recommendation with a Outperform. Stifel started tracking with a Buy rating for this stock on February 27, 2024, and assigned it a price target of $32. In a note dated February 27, 2024, Robert W. Baird initiated an Outperform rating and provided a target price of $32 on this stock.
The stock price of Alto Neuroscience Inc [ANRO] has been fluctuating between $3.56 and $24.00 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Alto Neuroscience Inc [NYSE: ANRO] shares were valued at $4.41 at the most recent close of the market. An investor can expect a potential return of 126.76% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -170.37%, Pretax Profit Margin comes in at -154.43%, and Net Profit Margin reading is -154.43%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.49 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.22 points at the first support level, and at 4.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.58, and for the 2nd resistance point, it is at 4.75.
Ratios To Look Out For
It’s worth pointing out that Alto Neuroscience Inc [NYSE:ANRO]’s Current Ratio is 13.09. On the other hand, the Quick Ratio is 13.09, and the Cash Ratio is 12.96.
Transactions by insiders
Recent insider trading involved Savitz Adam, CHIEF MEDICAL OFFICER, that happened on Jul 09 ’24 when 12069.0 shares were purchased. CHIEF MEDICAL OFFICER, Savitz Adam completed a deal on Jul 10 ’24 to buy 2931.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Smith Nicholas Conrad bought 6150.0 shares on Mar 28 ’24.
